Apria Healthcare, Inc., a leading provider in the home healthcare industry, is headquartered in the United States and operates extensively across various regions. Founded in 1993, the company has established itself as a trusted name in delivering innovative healthcare solutions, particularly in respiratory therapy, sleep apnea management, and home infusion services. With a commitment to enhancing patient care, Apria offers a range of core products and services, including durable medical equipment and comprehensive support for chronic conditions. Their unique approach combines advanced technology with personalised service, ensuring patients receive the best possible care in the comfort of their homes. Recognised for its market position, Apria Healthcare has achieved significant milestones, including numerous awards for quality and service excellence, solidifying its reputation as a leader in the home healthcare sector.
How does Apria Healthcare, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Apria Healthcare, Inc.'s score of 29 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Apria Healthcare, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Owens & Minor, Inc., and any emissions data or climate performance metrics would be inherited from this parent organisation. As of now, Apria Healthcare has not established any documented reduction targets or climate pledges. The absence of specific emissions figures and reduction initiatives indicates a potential area for improvement in their sustainability strategy. Given the context of the healthcare industry, which is increasingly focusing on reducing carbon footprints, it is essential for Apria Healthcare to develop and communicate clear climate commitments and targets to align with industry standards and expectations.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 11,403,000 | 00,000,000 | 0,000,000 | 0,000,000 | 000,000,000 |
| Scope 2 | 74,858,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 |
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 87% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Apria Healthcare, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.